Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XJ Hedgehog pathway inhibitors
L01XJ02 Sonidegib
D10729 Sonidegib phosphate (USAN) <US>
USP drug classification [BR:br08302]
Antineoplastics
Molecular Target Inhibitors
Sonidegib
D10729 Sonidegib phosphate (USAN)
Drug groups [BR:br08330]
Antineoplastic
DG01566 Hedgehog signaling inhibitor
DG01854 Sonidegib
D10729 Sonidegib phosphate
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG01854 Sonidegib
D10729 Sonidegib phosphate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Frizzled / Smoothened family
Smoothened
SMO
D10729 Sonidegib phosphate (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10729
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10729
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10729
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10729
Drug groups [BR:br08330]
Antineoplastic
DG01566 Hedgehog signaling inhibitor
DG01854 Sonidegib
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG01854 Sonidegib